Ken Fisher's MRK Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 24.07 M shares of Merck & Co., Inc. (MRK) worth $2.02 B, representing 0.73% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 50 quarters.
Based on 13F filings since 2013, Ken Fisher has maintained a long-term strategic position in MRK, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2025, adding 8.33 M shares. Largest reduction occurred in Q3 2025, reducing 945,571 shares.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's Merck & Co (MRK) Holding Value Over Time
Track share changes against reported price movement
Quarterly Merck & Co (MRK) Trades by Ken Fisher
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +1.21 M | Add 0.00% | 1.21 M | $44.32 |
| Q3 2013 | -53,389 | Reduce 4.43% | 1.15 M | $45.43 |
| Q4 2013 | +225 | Add 0.02% | 1.15 M | $47.76 |
| Q1 2014 | -392,902 | Reduce 34.08% | 759,861 | $54.17 |
| Q2 2014 | +6.01 M | Add 791.55% | 6.77 M | $55.20 |
| Q3 2014 | +72,555 | Add 1.07% | 6.85 M | $56.56 |
| Q4 2014 | +112,172 | Add 1.64% | 6.96 M | $54.19 |
| Q1 2015 | +40,861 | Add 0.59% | 7 M | $54.85 |
| Q2 2015 | +164,586 | Add 2.35% | 7.16 M | $54.32 |
| Q3 2015 | -78,433 | Reduce 1.09% | 7.09 M | $47.13 |
| Q4 2015 | +63,261 | Add 0.89% | 7.15 M | $50.40 |
| Q1 2016 | -129,779 | Reduce 1.82% | 7.02 M | $53.57 |
| Q2 2016 | +64,044 | Add 0.91% | 7.08 M | $56.62 |
| Q3 2016 | +60,992 | Add 0.86% | 7.14 M | $59.55 |
| Q4 2016 | -16,013 | Reduce 0.22% | 7.13 M | $56.17 |
| Q1 2017 | +63,610 | Add 0.89% | 7.19 M | $60.63 |
| Q2 2017 | +248,740 | Add 3.46% | 7.44 M | $61.15 |
| Q3 2017 | +201,223 | Add 2.70% | 7.64 M | $61.10 |
| Q4 2017 | +58,538 | Add 0.77% | 7.7 M | $53.69 |
| Q1 2018 | +314,490 | Add 4.08% | 8.02 M | $51.98 |
| Q2 2018 | +293,386 | Add 3.66% | 8.31 M | $57.92 |
| Q3 2018 | +123,598 | Add 1.49% | 8.43 M | $67.69 |
| Q4 2018 | +398,421 | Add 4.72% | 8.83 M | $72.91 |
| Q1 2019 | +58,102 | Add 0.66% | 8.89 M | $79.36 |
| Q2 2019 | +293,620 | Add 3.30% | 9.18 M | $80.01 |
| Q3 2019 | +245,841 | Add 2.68% | 9.43 M | $80.32 |
| Q4 2019 | -111,586 | Reduce 1.18% | 9.32 M | $86.78 |
| Q1 2020 | +18,316 | Add 0.20% | 9.34 M | $73.42 |
| Q2 2020 | +204,744 | Add 2.19% | 9.54 M | $73.79 |
| Q3 2020 | +183,816 | Add 1.93% | 9.72 M | $79.15 |
| Q4 2020 | +311,103 | Add 3.20% | 10.03 M | $78.05 |
| Q1 2021 | +296,702 | Add 2.96% | 10.33 M | $73.56 |
| Q2 2021 | -14,625 | Reduce 0.14% | 10.32 M | $77.77 |
| Q3 2021 | +316,452 | Add 3.07% | 10.63 M | $75.11 |
| Q4 2021 | +776,418 | Add 7.30% | 11.41 M | $76.64 |
| Q1 2022 | +422,415 | Add 3.70% | 11.83 M | $82.05 |
| Q2 2022 | +291,723 | Add 2.47% | 12.12 M | $91.17 |
| Q3 2022 | -87,363 | Reduce 0.72% | 12.04 M | $86.12 |
| Q4 2022 | +143,329 | Add 1.19% | 12.18 M | $110.95 |
| Q1 2023 | +165,927 | Add 1.36% | 12.35 M | $106.48 |
| Q2 2023 | +289,608 | Add 2.35% | 12.64 M | $115.39 |
| Q3 2023 | +703,069 | Add 5.56% | 13.34 M | $102.95 |
| Q4 2023 | +212,852 | Add 1.60% | 13.55 M | $109.02 |
| Q1 2024 | +319,201 | Add 2.36% | 13.87 M | $131.95 |
| Q2 2024 | +395,572 | Add 2.85% | 14.27 M | $123.80 |
| Q3 2024 | +387,420 | Add 2.72% | 14.65 M | $113.56 |
| Q4 2024 | +1.46 M | Add 9.95% | 16.11 M | $99.48 |
| Q1 2025 | +8.33 M | Add 51.73% | 24.45 M | $89.76 |
| Q2 2025 | +567,900 | Add 2.32% | 25.01 M | $79.16 |
| Q3 2025 | -945,571 | Reduce 3.78% | 24.07 M | $83.93 |
Ken Fisher's Merck & Co Investment FAQs
Ken Fisher first purchased Merck & Co., Inc. (MRK) in Q2 2013, acquiring 1,205,927 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held Merck & Co., Inc. (MRK) for 50 quarters since Q2 2013.
Ken Fisher's largest addition to Merck & Co., Inc. (MRK) was in Q1 2025, adding 24,445,797 shares worth $2.19 B.
According to the latest 13F filing for Q3 2025, Ken Fisher's firm, Fisher Asset Management, LLC, owns 24,068,126 shares of Merck & Co., Inc. (MRK), valued at approximately $2.02 B.
As of the Q3 2025 filing, Merck & Co., Inc. (MRK) represents approximately 0.73% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings.
Ken Fisher's peak holding in Merck & Co., Inc. (MRK) was 25,013,697 shares, as reported at the end of Q2 2025.